Ketojenik Diyet Tedavisinin Tarihsel Gelişimi

Authors

Ünsal Yılmaz

Synopsis

In the text authored by Prof. Dr. Ünsal Yılmaz, it is emphasized that epilepsy is a serious neurological disorder that exhibits resistance to antiepileptic drugs in approximately one-third of pediatric patients. Associated with supernatural forces and treated with primitive methods in ancient times, epilepsy was first posited by Hippocrates to be a disease originating from the brain, drawing attention to the beneficial effect of fasting on seizures. Although initial medical drugs such as potassium bromide and phenobarbital were used in the 19th and early 20th centuries, the search for alternative treatments continued due to their side effects and limitations. In 1911, the work of Guelpa and Marie, along with Dr. Conklin's fasting therapy applications, attracted the attention of the scientific community. Research revealed that fasting and carbohydrate restriction force the body to burn fat, producing ketone bodies with anticonvulsant effects. In 1921, Dr. Russell Wilder of the Mayo Clinic named this high-fat, low-carbohydrate nutritional model, which mimics the metabolic effects of fasting, the "ketogenic diet". Although its usage declined for a period with the introduction of new pharmaceutical drugs, it regained popularity for drug-resistant cases in the 1990s through the support of the Charlie Foundation and the media. Today, with derivatives such as the Modified Atkins Diet and Low Glycemic Index Treatment, the ketogenic diet has been practiced in Turkey since 2013 and is successfully utilized not only for epilepsy but also for obesity, diabetes, neoplastic, and other neurological disorders.

References

Fiest KM, Sauro KM, Wiebe S, et al. Prevalence and incidence of epilepsy: A systematic review and meta-analysis of international studies. Neurology. 2017;88(3):296-303. doi:10.1212/WNL.0000000000003509

Sillanpää M, Schmidt D. Natural history of treated childhood-onset epilepsy: prospective, long-term population-based study. Brain. 2006;129(Pt 3):617-624. doi:10.1093/brain/awh726

Keezer MR, Sisodiya SM, Sander JW. Comorbidities of epilepsy: current concepts and future perspectives. Lancet Neurol. 2016;15(1):106-115. doi:10.1016/S1474-4422(15)00225-2

Gross RA. A brief history of epilepsy and its therapy in the western hemisphere. 1992;12:65-74.

Temkin O. The falling sickness: a history of epilepsy from the Greeks to the beginnings of modern neurology. 2nd edn. Johns Hopkins Press, Baltimore, MD, 1971.

Hippocrates(?), The Sacred Disease. In: G.E.R. Lloyd (Ed.), Hippoeratic Writings, Penguin Books, Harmondsworth, 1978, pp. 237 251

Eadie MJ. Sir Charles Locock and potassium bromide. J R Coll Physicians Edinb. 2012;42(3):274-279. doi:10.4997/JRCPE.2012.317

Locock, C., Discussion of a paper by E.H. Sieveking: analysis of 52 cases of epilepsy observed by the author.

Yasiry Z, Shorvon SD. How phenobarbital revolutionized epilepsy therapy: the story of phenobarbital therapy in epilepsy in the last 100 years. Epilepsia. 2012;53 Suppl 8:26-39. doi:10.1111/epi.12026

Kim J. Clinical Neurophysiology Practice Ketogenic diet : Old treatment , new beginning. Clin Neurophysiol Pract. 2017;2:161-162. doi:10.1016/j.cnp.2017.07.001

Huisjen D. (2000) Today’s parallel bible. Zondervan Corp., Grand Rapids, MI; Mark 9:14–29, 2306–2308.

Guelpa G,Marie A. (1911) La lutte contre l‘e’pilepsie par la de’ sintoxication et par la re’e’ducation alimentaire. Rev TherMedico-Chirurgicale 78:8–13.

Höhn S, Dozières-puyravel B, Auvin S. Epilepsy & Behavior History of dietary treatment : Guelpa & Marie fi rst report of intermittent fasting for epilepsy in 1911. Epilepsy Behav. 2019;94:277-280. doi:10.1016/j.yebeh.2019.03.018

Freeman JM, Kelly MT, Freeman JB. (1994) The epilepsy diet treatment:an introduction to the ketogenic diet. Demos, New York.

Wilkinson JF. (1997) Look at me. Smithsonian 28:136–151.

Conklin HW. Cause and treatment of epilepsy. J Am Osteopath Assoc. 1922;26:11–14.

Geyelin HR. (1921) Fasting as a method for treating epilepsy. Med Rec 99:1037–1039.

Penfield W. Erickson TC. (1941) Epilepsy and cerebral localization: a study of the mechanism, treatment, and prevention of epileptic seizures. Charles C. Thomas, Baltimore. pp. 504–509.

Wheless JW. History of the ketogenic diet. Epilepsia. 2008 Nov;49 Suppl 8:3-5

Woodyatt RT. (1921) Objects and method of diet adjustment in diabetics. Arch Intern Med 28:125–141.

Gamble JL, Ross GS, Tisdall FF. The metabolism of fixed base during fasting. J Biol Chem. 1923;57:633–695.

Wilder RM. The effect of ketonemia on the course of epilepsy. Mayo Clin Bull. 1921;2:307.

Peterman MG. (1925) The ketogenic diet in epilepsy. JAMA 84:1979–1983.

McQuarrıe I, Keıth HM. Epılepsy ın chıldren: relatıonshıp of varıatıons ın the degree of ketonurıa to occurrence of convulsıons ın epıleptıc chıldren on ketogenıc dıets. Am J Dis Child. 1927;34(6):1013–1029.

Livingston S. (1972) Comprehensive management of epilepsy in infancy, childhood and adolescence. Charles C. Thomas, Springfield, IL, pp. 378–405.

Wick JY. The history of benzodiazepines. Consult Pharm J Am Soc Consult Pharm. 2013;28(9):538-548. doi:10.4140/TCP.n.2013.538

Huttenlocher PR, Wilbourn AJ, Signore JM. Medium-chain triglycerides as a therapy for intractable childhood epilepsy. Neurology. 1971;21(11):1097-1103. doi:10.1212/wnl.21.11.1097

Schwartz RH, Eaton J, Bower BD, Aynsley-Green A. Ketogenic diets in the treatment of epilepsy: short-term clinical effects. Dev Med Child Neurol. 1989;31(2):145-151. doi:10.1111/j.1469-8749.1989.tb03972.x

Livingston S, Pauli LL, Pruce I. Ketogenic diet in the treatment of childhood epilepsy. Dev Med Child Neurol. 1977;19:833–834.

Kinsman SL, Vining EP, Quaskey SA, Mellits D, Freeman JM. Efficacy of the ketogenic diet for intractable seizure disorders: review of 58 cases. Epilepsia. 1992;33(6):1132-1136. doi:10.1111/j.1528-1157.1992.tb01770.x

Neal EG, Chaffe H, Schwartz RH, et al. The ketogenic diet for the treatment of childhood epilepsy: a randomised controlled trial. Lancet Neurol. 2008;7(6):500-506. doi:10.1016/S1474-4422(08)70092-9

Kossoff EH, Krauss GL, McGrogan JR, Freeman JM. Efficacy of the Atkins diet as therapy for intractable epilepsy. Neurology. 2003;61(12):1789-1791. doi:10.1212/01.wnl.0000098889.35155.72

Pfeifer HH, Thiele EA. Low-glycemic-index treatment: a liberalized ketogenic diet for treatment of intractable epilepsy. Neurology. 2005;65(11):1810-1812. doi:10.1212/01.wnl.0000187071.24292.9e

Muzykewicz DA, Lyczkowski DA, Memon N, Conant KD, Pfeifer HH, Thiele EA. Efficacy, safety, and tolerability of the low glycemic index treatment in pediatric epilepsy. Epilepsia. 2009;50(5):1118-1126. doi:10.1111/j.1528-1167.2008.01959.x

Kossoff EH, Dorward JL, Turner Z, Pyzik PL. Prospective study of the modified atkins diet in combination with a ketogenic liquid supplement during the initial month. J Child Neurol. 2011;26(2):147-151. doi:10.1177/0883073810375718

Rubenstein JE, Kossoff EH, Pyzik PL, Vining EPG. Experience in the Use of the Ketogenic Diet as Early Therapy. 2005:31-34.

Weber DD, Aminzadeh-Gohari S, Tulipan J, Catalano L, Feichtinger RG, Kofler B. Ketogenic diet in the treatment of cancer - Where do we stand? Mol Metab. 2020;33:102-121. doi:10.1016/j.molmet.2019.06.026

Verrotti A, Iapadre G, Pisano S, Coppola G. Ketogenic diet and childhood neurological disorders other than epilepsy: an overview. Expert Rev Neurother. 2017;17(5):461-473. doi:10.1080/14737175.2017.1260004

https://clinicaltrials.gov/ct2/results?recrs=&cond=ketogenic+diet&term=&cntry=&state=&city=&dist=. Erişim:02.03.2021.

Published

September 30, 2021

License

License